These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 10846906

  • 21. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.
    Mahajan S, Kalra OP, Asit KT, Ahuja G, Kalra V.
    Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119
    [Abstract] [Full Text] [Related]

  • 22. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M, Akca R, Sarandol E, Dilek K.
    J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
    [Abstract] [Full Text] [Related]

  • 23. [Characteristics of renal urea excretion in chronic renal insufficiency].
    Ermakova IP.
    Vrach Delo; 1972 Aug; 8():57-61. PubMed ID: 5073182
    [No Abstract] [Full Text] [Related]

  • 24. [Extracellular and intracellular water-electrolyte changes and acid-base equilibrium changes after extracorporeal hemodialysis in chronic uremic patients].
    Acquarone N, Bertocchi I, De Ferrari G, Gurreri G, Menozzi PG, Tizianello A.
    Minerva Nefrol; 1970 Aug; 17(6):190-7. PubMed ID: 5516054
    [No Abstract] [Full Text] [Related]

  • 25. Pyrazinamide and pyrazinoic acid pharmacokinetics in patients with chronic renal failure.
    Stamatakis G, Montes C, Trouvin JH, Farinotti R, Fessi H, Kenouch S, Méry JP.
    Clin Nephrol; 1988 Oct; 30(4):230-4. PubMed ID: 3214968
    [Abstract] [Full Text] [Related]

  • 26. Profound mishandling of protein glycation degradation products in uremia and dialysis.
    Agalou S, Ahmed N, Babaei-Jadidi R, Dawnay A, Thornalley PJ.
    J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
    [Abstract] [Full Text] [Related]

  • 27. [The intervals of ventricular systole in uremic patients treated with periodic hemodialysis. Polygraphic study].
    Sodi A, Rizzo M, Durval A, Biagioni-Sodi A, Turini D, Pampanini A.
    Mal Cardiovasc; 1968 May; 9(3):441-70. PubMed ID: 5705928
    [No Abstract] [Full Text] [Related]

  • 28. [Surgery in uremic patients on chronic hemodialysis].
    Robecchi A, Ginardi A, Scollo MA, Scaglia M, Cattaneo U, Piemontesi F, Bergoglio D, Fronda GR.
    Minerva Chir; 1987 Nov 30; 42(22):1889-92. PubMed ID: 3431717
    [No Abstract] [Full Text] [Related]

  • 29. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment.
    Rysz J, Potargowicz E, Banach M, Luczyńska M, Stolarek R, Białasiewicz P, Kasielski M, Ciałkowska-Rysz A, Nowak D.
    Arch Immunol Ther Exp (Warsz); 2006 Nov 30; 54(5):347-55. PubMed ID: 17031465
    [Abstract] [Full Text] [Related]

  • 30. Sex variation in ascorbic acid catabolism.
    Muddeshwar MG, Nath N, Chari SN.
    Indian J Physiol Pharmacol; 1992 Oct 30; 36(4):263-6. PubMed ID: 1291479
    [Abstract] [Full Text] [Related]

  • 31. Influence of the ionic dialysance monitor on Kt measurement in hemodialysis.
    Maduell F, Vera M, Arias M, Serra N, Blasco M, Bergadá E, Fontsere N, Cases A, Campistol JM.
    Am J Kidney Dis; 2008 Jul 30; 52(1):85-92. PubMed ID: 18455852
    [Abstract] [Full Text] [Related]

  • 32. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
    Maduell F.
    Nefrologia; 2005 Jul 30; 25 Suppl 2():15-8. PubMed ID: 16050396
    [Abstract] [Full Text] [Related]

  • 33. Separation of ascorbic acid, dehydroascorbic acid, diketogulonic acid and glucose by isocratic elution from a column of a hydrophilic gel.
    Seki T, Yamaguchi Y, Noguchi K, Yanagihara Y.
    J Chromatogr; 1985 Sep 20; 332():283-6. PubMed ID: 4055943
    [Abstract] [Full Text] [Related]

  • 34. Bone fluoride in patients with uremia maintained by chronic hemodialysis.
    Kim D, Del Greco F, Hefferen JJ, Levin NW.
    Trans Am Soc Artif Intern Organs; 1970 Sep 20; 16():474-8. PubMed ID: 5454201
    [No Abstract] [Full Text] [Related]

  • 35. [Ambulatory hemodialysis in the treatment of chronic uremia].
    Dzhavad-Zade MD, Sultanov FM, Aliev SI.
    Klin Med (Mosk); 1978 Feb 20; 56(2):83-5. PubMed ID: 633832
    [No Abstract] [Full Text] [Related]

  • 36. Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound.
    Giannattasio P, Minutolo R, Bellizzi V, Di Iorio BR, Scigliano R, Zamboli P, Venditti G, Manganelli R, De Simone W, Aucella F, Stallone C, Spiezia S, Conte G, De Nicola L.
    Am J Kidney Dis; 2006 Jun 20; 47(6):1045-54. PubMed ID: 16731300
    [Abstract] [Full Text] [Related]

  • 37. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A, Bahceci M, Yilmaz ME, Turgut C, Kara IH.
    Saudi Med J; 2005 May 20; 26(5):786-91. PubMed ID: 15951871
    [Abstract] [Full Text] [Related]

  • 38. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K, Stompór T, Gryz E, Szczudlik A, Drozdz M, Kraśniak A, Sułowicz W.
    Przegl Lek; 2007 May 20; 64(6):423-30. PubMed ID: 18159852
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease.
    Teichert J, Tuemmers T, Achenbach H, Preiss C, Hermann R, Ruus P, Preiss R.
    J Clin Pharmacol; 2005 Mar 20; 45(3):313-28. PubMed ID: 15703366
    [Abstract] [Full Text] [Related]

  • 40. [Problems of perodic hemodialysis treatment in patients with chronic renal failure].
    Migone L.
    Munch Med Wochenschr; 1969 Mar 28; 111(13):725-31. PubMed ID: 5818659
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.